
Pharmaceuticals / Healthcare · NSE
Medicamen Organics Limited, founded in 1995, is a trusted pharmaceutical company specializing in the development, manufacturing, and distribution of a wide range of pharmaceutical dosages, including tablets, capsules, syrups, ointments, gels, and dry powders. Catering to both government and private sectors as a contract manufacturer, the company offers 84 products across various therapeutic categories, such as antibacterials, antifungals, antidiabetics, antihypertensives, and multivitamin preparations. Medicamen Organics has a strong domestic presence and exports to multiple international markets, including Africa, CIS, and Southeast Asia. The company operates two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, spanning 21,536 square feet. With partnerships with 38 domestic contract manufacturers and 12 merchant exporters, the company employed 116 people as of September 30, 2023, ensuring high-quality production and global reach.
Price Band
₹32 – ₹34
Issue Size
₹10.54 Cr
Lot Size
4000 shares
GMP
+205.9%
Est. Listing
₹104
at current GMP
Subscribed
965.49x
overall
Open
21 Jun 2024
Close
25 Jun 2024
Allotment
26 Jun 2024
Refund
27 Jun 2024
Demat Credit
28 Jun 2024
Listing
28 Jun 2024
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹34
Band: ₹32 – ₹34
Estimated Listing Price
₹104
Upper price + GMP
Lot Size
4000 shares
Min investment ₹1,36,000
Estimated Profit / Lot
₹2,80,000
4000 × ₹70
Grey Market Premium trend
+₹70
▲ 0 today
Updated 11 months ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 10 Mar 2025 | +₹70 | 205.9% | ₹104 |
| 14 Nov 2025 | +₹70 | 205.9% | ₹104 |
| 17 Nov 2025 | +₹70 | 205.9% | ₹104 |
| 26 Nov 2025 | +₹70 | 205.9% | ₹104 |
GMP is unofficial market data. Not a guarantee of listing performance.
Medicamen Organics Limited is bringing an initial public offering (IPO) in the Pharmaceuticals / Healthcare sector with an aggregate issue size of ₹10.54 Crores. The shares are offered at a price band of ₹32 to ₹34 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 4000 shares (approx. ₹1,36,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2024-06-28, while un-allotted funds or UPI block mandates will be released on 2024-06-27.
The latest grey market premium for Medicamen Organics Limited IPO is ₹70, which indicates an expected listing price of ₹104.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.